Brief: Lavipharm FY 2014 net loss widens to 28.8 mln euros
March 31 (Reuters) - Lavipharm SA LPHr.AT :
* FY 2014 turnover at 30.3 million euros ($32.52 million)
versus 30.1 million euros year ago
* FY 2014 EBITDA loss at 8.7 million euros versus 1.9
million euros year ago
* FY 2014 net loss at 28.8 million euros versus 11.3 million
euros year ago
* Net cash on Dec. 31, 2014 at 2.4 million euros versus 4.2
million euros year ago
Source text: http://bit.ly/1NzZUoH
Further company coverage: LPHr.AT
($1 = 0.9316 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY